Despite a declining trend, the number of adults in the U.S. who say they did not adhere to their asthma treatment because of ...

Price stops 1 in 6 US adults with asthma from taking their life-saving medications as prescribed - An estimated 22 million ...

John “Jack” Hemphill, a program manager in the Rutgers Office of Population Health and co-convenor of Asthma Corps, said the ...

A new injection, benralizumab, outperforms traditional steroids in treating asthma and COPD attacks, reducing treatment ...

Adults with asthma with cost-related medication nonadherence were more likely to have asthma attacks and emergency department ...

The first new treatment for asthma attacks in 50 years is a drug already available—and it’s 4x more effective than steroid ...

Earlier this year, researchers of Brigham and Women’s Hospital Harvard Medical School looked at clinical trials to show how six biologics, in particular, improve lung function; cut down on steroid use ...

Massachusetts families are still struggling to find alternatives almost a year after GlaxoSmithKline canceled a widely ...

Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulmonary ...

Despite a fall in the number of people with asthma over the past decade who say that cost has stopped them taking their meds ...

In this exclusive MedPage Today video, Michael E. Wechsler, MD, a pulmonologist at National Jewish Health in Denver, ...

Wheezing, shortness of breath, tightness in the chest: the symptoms of an asthma attack can be scary, especially for children ...